• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

V 结构域免疫球蛋白抑制 T 细胞活化蛋白的结构和功能结合表位

Structure and Functional Binding Epitope of V-domain Ig Suppressor of T Cell Activation.

机构信息

Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.

Stanford Synchrotron Radiation Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025, USA.

出版信息

Cell Rep. 2019 Sep 3;28(10):2509-2516.e5. doi: 10.1016/j.celrep.2019.07.073.

DOI:10.1016/j.celrep.2019.07.073
PMID:31484064
Abstract

V-domain immunoglobulin (Ig) suppressor of T cell activation (VISTA) is an immune checkpoint protein that inhibits the T cell response against cancer. Similar to PD-1 and CTLA-4, a blockade of VISTA promotes tumor clearance by the immune system. Here, we report a 1.85 Å crystal structure of the elusive human VISTA extracellular domain, whose lack of homology necessitated a combinatorial MR-Rosetta approach for structure determination. We highlight features that make the VISTA immunoglobulin variable (IgV)-like fold unique among B7 family members, including two additional disulfide bonds and an extended loop region with an attached helix that we show forms a contiguous binding epitope for a clinically relevant anti-VISTA antibody. We propose an overlap of this antibody-binding region with the binding epitope for V-set and Ig domain containing 3 (VSIG3), a purported functional binding partner of VISTA. The structure and functional epitope presented here will help guide future drug development efforts against this important checkpoint target.

摘要

V 结构域免疫球蛋白(Ig)抑制 T 细胞活化(VISTA)是一种免疫检查点蛋白,可抑制针对癌症的 T 细胞反应。与 PD-1 和 CTLA-4 类似,VISTA 的阻断可促进免疫系统清除肿瘤。在这里,我们报告了难以捉摸的人类 VISTA 细胞外结构域的 1.85Å 晶体结构,由于缺乏同源性,因此需要采用组合的 MR-Rosetta 方法来确定结构。我们强调了使 VISTA 的免疫球蛋白可变(IgV)样折叠在 B7 家族成员中独一无二的特征,包括两个额外的二硫键和一个带有附加螺旋的扩展环区,我们证明该环区形成了与临床相关的抗 VISTA 抗体的连续结合表位。我们提出该抗体结合区域与 V 集和 Ig 域包含 3(VSIG3)的结合表位重叠,VSIG3 是 VISTA 的假定功能结合伙伴。此处呈现的结构和功能表位将有助于指导针对该重要检查点靶标的未来药物开发工作。

相似文献

1
Structure and Functional Binding Epitope of V-domain Ig Suppressor of T Cell Activation.V 结构域免疫球蛋白抑制 T 细胞活化蛋白的结构和功能结合表位
Cell Rep. 2019 Sep 3;28(10):2509-2516.e5. doi: 10.1016/j.celrep.2019.07.073.
2
Structural Basis of VSIG3: The Ligand for VISTA.VSIG3 的结构基础:VISTA 的配体。
Front Immunol. 2021 Mar 25;12:625808. doi: 10.3389/fimmu.2021.625808. eCollection 2021.
3
An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA.一种工程化抗体结合了一个独特的表位,是一种有效的鼠源和人源 VISTA 的抑制剂。
Sci Rep. 2020 Sep 16;10(1):15171. doi: 10.1038/s41598-020-71519-4.
4
Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma.三种免疫检查点(VISTA、CTLA-4、PD-1)通路对鳞状细胞癌抗肿瘤反应的不同贡献。
Oral Oncol. 2016 Jun;57:54-60. doi: 10.1016/j.oraloncology.2016.04.005. Epub 2016 May 3.
5
The VISTA/VSIG3/PSGL-1 axis: crosstalk between immune effector cells and cancer cells in invasive ductal breast carcinoma.VISTA/VSIG3/PSGL-1 轴:免疫效应细胞和浸润性导管乳腺癌细胞之间的串扰。
Cancer Immunol Immunother. 2024 Jun 4;73(8):136. doi: 10.1007/s00262-024-03701-w.
6
VISTA is an immune checkpoint molecule for human T cells.VISTA 是一种人类 T 细胞的免疫检查点分子。
Cancer Res. 2014 Apr 1;74(7):1924-32. doi: 10.1158/0008-5472.CAN-13-1504.
7
Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule Inhibitors.新型 VISTA 小分子抑制剂的设计、合成与抗肿瘤活性评价。
J Med Chem. 2024 Mar 14;67(5):3590-3605. doi: 10.1021/acs.jmedchem.3c02039. Epub 2024 Feb 27.
8
VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy.VISTA:静止的调解者和癌症免疫治疗的有前途的靶点。
Trends Immunol. 2021 Mar;42(3):209-227. doi: 10.1016/j.it.2020.12.008. Epub 2021 Jan 23.
9
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead.V 型免疫球蛋白结构域 T 细胞激活抑制因子(VISTA)在癌症治疗中的作用:经验教训与未来展望。
Front Immunol. 2021 May 19;12:676181. doi: 10.3389/fimmu.2021.676181. eCollection 2021.
10
The Expression Pattern and Clinical Significance of the Immune Checkpoint Regulator VISTA in Human Breast Cancer.免疫检查点调节剂 VISTA 在人乳腺癌中的表达模式及临床意义。
Front Immunol. 2020 Oct 29;11:563044. doi: 10.3389/fimmu.2020.563044. eCollection 2020.

引用本文的文献

1
A Four Amino Acid Intracellular Motif of VISTA Blocks Growth Receptor Signaling in Cancer Cells to Induce Tumor Suppression.VISTA的一个四氨基酸细胞内基序可阻断癌细胞中的生长受体信号传导,从而诱导肿瘤抑制。
Cancer Res. 2025 Jul 14. doi: 10.1158/0008-5472.CAN-24-4774.
2
Negative Immune Checkpoint Inhibitors.阴性免疫检查点抑制剂
Pharmaceutics. 2025 May 28;17(6):713. doi: 10.3390/pharmaceutics17060713.
3
[IGSF11: A Novel Target for Cancer Immunotherapy].[免疫球蛋白超家族成员11:癌症免疫治疗的新靶点]
Zhongguo Fei Ai Za Zhi. 2025 May 20;28(5):371-378. doi: 10.3779/j.issn.1009-3419.2025.106.14.
4
Emerging new immune checkpoint inhibitors in solid tumor immunotherapy.实体瘤免疫治疗中新兴的新型免疫检查点抑制剂
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 11. doi: 10.1007/s00210-025-04131-w.
5
YAP/TEAD4/SP1-induced VISTA expression as a tumor cell-intrinsic mechanism of immunosuppression in colorectal cancer.YAP/TEAD4/SP1诱导的VISTA表达作为结直肠癌免疫抑制的肿瘤细胞内在机制。
Cell Death Differ. 2025 May;32(5):911-925. doi: 10.1038/s41418-025-01446-2. Epub 2025 Jan 28.
6
VISTA-induced tumor suppression by a four amino acid intracellular motif.VISTA通过一个四氨基酸胞内基序诱导肿瘤抑制。
bioRxiv. 2025 Jan 5:2025.01.05.631401. doi: 10.1101/2025.01.05.631401.
7
FOXO1 pathway activation by VISTA immune checkpoint restrains pulmonary ILC2 functions.VISTA免疫检查点激活FOXO1信号通路会抑制肺部2型固有淋巴细胞的功能。
J Clin Invest. 2025 Jan 2;135(4):e184932. doi: 10.1172/JCI184932.
8
VISTA in hematological malignancies: a review of the literature.VISTA在血液系统恶性肿瘤中的研究:文献综述
Front Immunol. 2024 Dec 17;15:1466839. doi: 10.3389/fimmu.2024.1466839. eCollection 2024.
9
Mapping the Binding Hotspots and Transient Binding Pockets on V-Domain Immunoglobulin Suppressor of T Cell Activation Protein Surface.绘制T细胞活化蛋白表面V结构域免疫球蛋白抑制因子上的结合热点和瞬时结合口袋。
ACS Omega. 2024 Nov 23;9(49):48657-48669. doi: 10.1021/acsomega.4c07757. eCollection 2024 Dec 10.
10
A pair of promising immune checkpoints PSGL-1 and VISTA from immunotolerance to immunotherapy.一对从免疫耐受到免疫治疗的有前景的免疫检查点PSGL-1和VISTA。
Biomark Res. 2024 Dec 2;12(1):151. doi: 10.1186/s40364-024-00693-8.